Previous Article | Next Article 
Journal of Virology, October 2000, p. 9347-9352, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Foreign and Chimeric External Scaffolding Proteins
as Inhibitors of Microviridae Morphogenesis
April D.
Burch and
Bentley A.
Fane*
Department of Veterinary Sciences and
Microbiology, University of Arizona, Tucson, Arizona 85721
Received 18 April 2000/Accepted 27 July 2000
 |
ABSTRACT |
Viral assembly is an ideal system in which to investigate the
transient recognition and interplay between proteins. During morphogenesis, scaffolding proteins temporarily associate with structural proteins, stimulating conformational changes that promote assembly and inhibit off-pathway reactions. Microviridae
morphogenesis is dependent on two scaffolding proteins, an internal and
an external species. The external scaffolding protein is the most
conserved protein within the Microviridae, whose canonical
members are
X174, G4, and
3. However, despite 70% homology on
the amino acid level, overexpression of a foreign
Microviridae external scaffolding protein is a potent
cross-species inhibitor of morphogenesis. Mutants that are resistant to
the expression of a foreign scaffolding protein cannot be obtained via
one mutational step. To define the requirements for and constraints on
scaffolding protein interactions, chimeric external scaffolding
proteins have been constructed and analyzed for effects on in vivo
assembly. The results of these experiments suggest that at least two
cross-species inhibitory domains exist within these proteins; one
domain most likely blocks procapsid formation, and the other allows
procapsid assembly but blocks DNA packaging. A mutation conferring
resistance to the expression of a chimeric protein (chiDr)
that inhibits DNA packaging was isolated. The mutation maps to gene A,
which encodes a protein essential for packaging. The chiDr mutation confers resistance only to a
chimeric D protein; the mutant is still inhibited by the expression of
foreign D proteins. The results presented here demonstrate how closely
related proteins could be developed into antiviral agents that
specifically target virion morphogenesis.
 |
INTRODUCTION |
The proper assembly of viral
proteins and nucleic acids into a biologically active virion involves
numerous and diverse macromolecular interactions. While structural
proteins must correctly interact with other structural proteins, proper
morphogenesis is equally dependent on interactions between structural
and scaffolding proteins. Viral scaffolding proteins are transiently
associated with morphogenetic intermediates but are not found in the
mature viral particle (10, 12, 17, 22). These proteins
promote the efficiency and fidelity of particle formation by ensuring
proper interactions between viral proteins, promoting the nucleation of
assembly, and aiding in the formation of a precisely sized capsid
(13, 16, 19). In the Microviridae, assembly is
dependent on two scaffolding proteins, an internal and an external
species. The assembly pathway has been extensively characterized
(8), and the atomic structures of both the
X174 virion
and a morphogenetic intermediate containing a full complement of
scaffolding proteins have been solved (2, 3, 14, 15).
Therefore, the results of genetic and biochemical analyses can be
interpreted within a structural context.
The Microviridae assembly pathway is illustrated in Fig.
1. The first detectable morphogenetic
intermediates are the 9S and 6S particles, respective pentamers of the
viral coat and spike proteins. In a reaction mediated by the internal
scaffolding (or B) protein, these intermediates associate, forming the
12S particle. Twelve 12S particles are then organized into the
procapsid by 240 copies of the external scaffolding (or D) protein. The
preinitiation complex, consisting of one copy of viral proteins A and
C, replicative-form (RF) DNA, and the host cell Rep protein, associates
with the procapsid, probably along a twofold axis of symmetry
(5), forming the 50S complex. Single-stranded genomic DNA is
then concurrently synthesized and packaged. The internal scaffolding
protein is extruded during this reaction, yielding the infectious
provirion, which may represent the end of the intracellular assembly
pathway. The external scaffolding protein may dissociate upon cell
lysis. External scaffolding proteins are not unique to the
Microviridae. The coliphage P4 Sid protein and the triplex
proteins of the Herpesviridae perform analogous functions
(13, 23). Although the Microviridae morphogenetic
pathway has been well characterized, the mechanism in which viral
scaffolding proteins enable nascent intermediates to reach a
biologically active form remains somewhat obscure. Here we report that
the expression of closely related external scaffolding proteins
inhibits morphogenesis. Using chimeric proteins, we have defined the
existence of two inhibitory domains. These results have implications
for the use of closely related proteins in the development of antiviral
analogs specific to viral morphogenesis.


View larger version (56K):
[in this window]
[in a new window]
|
FIG. 1.
(A) The Microviridae morphogenetic pathway.
In a reaction mediated by the internal scaffolding (or B) protein, 9S
and 6S pentamers associate, forming the 12S particle. Twenty external
scaffolding (or D) proteins add to this intermediate, which is then
organized into the procapsid. The DNA binding (or J) protein enters the
morphogenetic pathway during the packaging reaction, perhaps mediating
the extrusion of the internal scaffold. Maturation is complete upon
dissociation of the external scaffolding protein. (B) The four D
proteins associated with each asymmetric unit (2). The
subunits are designated D1 through D4; the amino and carboxyl termini
are indicated where possible. The first helices of D1 and D4 are
depicted.
|
|
 |
MATERIALS AND METHODS |
Phage plating, media, burst experiments, stock preparation,
generation of RF DNA, generation of radioactive lysates, and DNA
isolation.
The reagents, media, buffers, and protocols for burst
experiments and single-stranded DNA isolation have been previously
described (6), as has the generation and isolation of RF DNA
(1). The protocols for producing radioactive lysates and
subsequent sucrose gradient sedimentation analyses are the same as
those previously described exception that [35S]methionine
and [35S]cysteine were used to label viral proteins
(5).
Bacterial strains.
The Escherichia coli C strains
C122 (supo), BAF5 (supE), and BAF30
recA have been previously described (1, 6). The
C900 slyD host, used for the generation of radioactive
lysates, was obtained from R. Young, Texas A&M University. The
slyD mutation confers resistance to
X174
E-protein-mediated lysis (18).
Phage mutants.
The protocol used for
oligonucleotide-mediated mutagenesis has been previously described
(7). To generate the
X174 NheI/PvuI strain,
X174 am(D)Q22 DNA (7) was annealed to
a mutagenic primer designed to concurrently eliminate the amber
mutation and add the NheI restriction site. The mutant was
selected for by the loss of the amber phenotype by transfection into
C122 (supo). The NheI restriction
site is located just after the region of the gene encoding the first
helix in the atomic structure of the D protein (2, 3).
X174 NheI DNA was mutagenized to introduce the previously
described (9) am(J)S7 mutation. The
PvuI site was then introduced with a mutagenic primer
designed to concurrently eliminate the amber mutation and add the
PvuI restriction site. Again, selection against the amber
phenotype was used. The PvuI site served as a marker for the
identification of the chimeric genes (see below). The
am(E)W4 mutation was then introduced as previously described
(4). Similar methods were used to generate the
3
NheI,
3 NheI/am(E)W4,
3am(J)S7, and
3am(D)Q20 mutations. The
PvuI and NheI restriction sites do not alter the
amino acid sequences of the
X174 or
3 D and J proteins.
Due to the high reversion frequencies of the am(D)
mutations, double am(D) mutants and frameshift mutants were
also generated. A second amber mutation was introduced into
X174
am(D)Q22 DNA at codon 18. Cells carrying a clone of the
X174 D gene were transfected. The double amber mutant was
distinguished from the parental single amber mutant by its inability to
propagate in strain BAF5 (supE), which is unable to support
the growth of the double amber mutant. A frameshift mutation within the
3 D gene was generated by cutting
3 NheI RF DNA with
NheI and filling in the overhangs, followed by blunt-end
ligation using standard protocols (20). Cells harboring a
clone of the
3 D gene were transfected, and the mutant was identified by complementation-dependent phenotype. All mutations were
verified by a direct sequence analysis.
X174
chiDr mutants that had gained the ability to
propagate in the presence of the chimeric
X/
3 D protein were
selected by plating 108 wild-type phage on cells harboring
a clone of the chimeric
X/
3 D gene (see below).
Cloning of the
X174 and
3 DJ,
X and
3 J, and both
chimeric D genes.
Single-stranded DNA from both
X174
NheI/PvuI am(E)W4 and
3
NheI/PvuI am(E)W4 mutants served as
the template for PCR amplification of the D and J genes. The DJ
fragments were cloned directly into the TOPO TA vector (Invitrogen) and
then subcloned into the pSE420 expression vector (Invitrogen). The
cloned genes are under lactose induction. The
3 J gene was cloned
into pSE420 by digesting
3 RF DNA with HinPI and
Bsp120I and digesting plasmid DNA with BstBI and
NotI. All clones were verified by complementation
experiments and RF digests. The clone of the
X174 J gene has been
previously described (9).
To construct the chimeric D genes, plasmid DNA from the
3 and
X174 DJ clones was digested with NheI and
Bsp120I, yielding fragments encoding
helices 2 to 7 of
gene D and the entire J gene. Following ligation and transformation,
putative chimeric clones were identified by the ability to complement
an am(J) mutant under low induction and verified by
restriction enzyme digestion with EcoRV and PvuI.
The chimeric D genes were also verified by direct DNA sequence analysis.
 |
RESULTS |
Cross-functional and cross-species inhibition analysis of the
external scaffolding proteins.
To determine whether the
X174
and
3 external scaffolding proteins were capable of
cross-complementation, nullD mutants were plated on cell lines
harboring clones of the
X174 or
3 D and J genes (Table
1). Despite 70% identity in amino acid
sequence of the proteins, no cross-complementation was observed. Both
null D mutants plated with efficiencies at least 1 order of magnitude below the reversion frequencies of the nullD mutations, as assayed on
the C122 (supo) host. The failure to recover
revertants suggested that the expression of the foreign proteins might
confer cross-species inhibition. To determine if the expression of the
foreign external scaffolding protein or DNA binding protein was
affecting wild-type morphogenesis, wild-type
X174 and
3 were
plated on DJ plasmid-containing hosts and hosts harboring a clone of
only the J genes. Expression of the J proteins failed to cross-inhibit
either species of wild type, indicating that cross-inhibition was due
to the overexpression of the scaffolding proteins.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
EOPs of wild-type, nullD, and
chiDr strains of X174 and 3 in cells
expressing foreign and chimeric external
scaffolding proteinsa
|
|
Inhibition was very dependent on cell growth phase and induction
conditions; therefore, ranges are reported. Low induction conditions
were defined as those needed to obtain EOP (efficiency of plating)
values of 1.0 in complementation experiments. For example, the cloned
X174 D gene will complement the
X174 nullD mutant at an
isopropyl-
-D-thiogalactopyranoside (IPTG) concentration of 5.0 µM, using either log- or stationary-phase cells to seed the
plate. This standard condition gave similar results with every cloned
gene. High induction conditions were obtained by using an IPTG
concentration of 50 µM and seeding plates with exponentially growing cells.
Characterization of inhibitory domains.
As shown in Fig.
2, divergent residues are localized to
two distinct regions within the D proteins: amino acids comprising
helix 1 and the C terminus comprising loop 6 and the tip of
helix 7 in the atomic structure (2, 3, 11, 21). To determine whether
one or both of these domains confer inhibitory effects, chimeric genes
were constructed and the proteins were expressed in vivo. The
X/
3
protein contains
helix 1 from
X174; the remaining part of the
protein is derived from
3. The opposite construct (
3/
X)
contains
helix 1 from
3, with the remaining portion of the
protein derived from
X174 (Fig. 2). Table 1 shows that neither
chimeric gene can complement a nullD mutant. However, inhibition of the
wild type was observed, suggesting that the chimeric proteins retain
enough function to enter into the morphogenetic pathway. Expression of
the chimeric protein possessing the
X174
helix 1 inhibits
X174 morphogenesis (Table 1) even under low induction conditions and
weakly inhibits
3 morphogenesis. Likewise, expression of the
construct with
helix 1 from
3 strongly inhibits
3
morphogenesis but weakly inhibits
X174 morphogenesis. These results
suggest that both domains confer some level of inhibition.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Sequence alignment of the X174 and 3 external
scaffolding proteins. (B) Generation of the X/ 3 chimeric gene.
(C) Verification of the X/ 3 chimeric gene.
|
|
Isolation of a
X174 mutant resistant to the expression of the
X/
3 chimeric external scaffolding protein.
To isolate a
X174 mutant that could efficiently propagate in the presence of the
chimeric
X/
3 D protein, 108 wild-type phage were
plated on the cells expressing the chimeric protein at high induction
conditions. The chiDr mutant was identified by
its ability to consistently plate with EOPs near 1.0 in the presence of
the chimeric protein. Initially 80% of the
chiDr genome was sequenced. Only one base change
was found. The mutation confers a valine
alanine change at amino acid
286 in protein A. This region of gene A does not overlap gene B. To
confirm that this base change was solely responsible for the
ChiDr phenotype, the mutant A gene was moved into another
wild-type background. The phenotype bred true.
The A protein initiates both stage II and stage III DNA synthesis.
During stage II DNA synthesis, protein A mediates the semiconservative replication of double-stranded RF DNA. This stage of DNA replication occurs independently of procapsid morphogenesis. In stage III DNA
replication, single-stranded genomic DNA is concurrently synthesized and packaged. This stage of DNA synthesis cannot occur in the absence
of procapsids (8). The packaging preinitiation complex, consisting of viral proteins A and C and the host cell Rep protein, must dock to a fully formed procapsid. The location of the
chiDr substitution suggests that chimeric
X/
3 D protein, more specifically
helices 2 to 6, inhibits DNA
packaging, not procapsid formation (see below).
The
X174 chiDr mutant was assayed for the
ability to grow in cells overexpressing the wild-type
3 and chimeric
3/
X external scaffolding proteins. Although inhibition was
observed in cells expressing the
3 D protein (Table 1), it was
considerably less than that obtained for wild-type
X174, comparable
to that observed for wild-type
X174 in cells expressing the
3/
X chimera. In addition, the chiDr
mutation appears to have little or no effect on growth in the presence
of the
3/
X protein. These data suggest that two cross-species inhibitory domains exist in the external scaffolding proteins.
A
X174 chiDr/amD/amD mutant was
constructed to determine whether chiDr mutation
allowed for the utilization of the chimeric
X/
3 protein in
plating assays. The chimeric gene was unable to complement the
amD mutation in the chiDr background
(data not shown). The low level of inhibition (10
2) of
wild-type
X174 growth by the
3/
X chimeric protein proved too
refractory for the isolation of
X174 resistant mutants and experiments described below.
In vivo analysis of wild-type inhibition by foreign and chimeric
scaffolds.
The location of the chiDr
mutation in gene A suggests that the
X/
3 protein does not block
procapsid formation but blocks DNA packaging. To test this hypothesis,
the assembly intermediates synthesized in wild-type
X174-infected
cells were analyzed by sucrose gradient sedimentation as described in
Materials and Methods. The sedimentation profiles of
35S-labeled viral products are presented in Fig.
3. In cells expressing the
X174 D
protein, infectious virion (114S) and degraded procapsid structures
(70S) were detected. However, in the presence of the chimeric
X/
3
protein, only procapsids (108S) and degraded procapsids were present.
This result is consistent with a block in DNA packaging and the
location of the chiDr mutation in gene A, since
the A protein must interact with the procapsid during DNA packaging. In
cells expressing the
3 external scaffolding protein, only low levels
of procapsids and/or degraded procapsids were detected, suggesting that
morphogenesis is inhibited before procapsid formation.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Sedimentation analysis of particles produced in the
presence of foreign and chimeric scaffolding proteins. Symbols: ,
wild-type 3 grown in cells overexpressing the 3 D protein
(control); , wild-type X174 grown in cells overexpressing the
3 D protein; , wild-type X174 grown in cells overexpressing
the X 3 chimeric D protein.
|
|
Isolation of a
X174 multiple mutant resistant to the expression
of the
3 chimeric external scaffolding protein.
Although it was
not possible to isolate a
X174 mutant resistant to expression of the
3 external scaffolding protein via one mutational step (data not
shown), a mutant was obtained in a multistep selection. Cells
expressing the
3 external scaffolding protein were infected at a
multiplicity of 0.01 in liquid culture. Induction conditions were kept
at levels that produced an EOP of 10
2 in plating assays.
The ForDr (foreign D resistance) phenotype also confers
resistance to both chimeric scaffolding proteins. The entire
forDr genome has been sequenced. Two single-base
insertions have been found at the end of gene C, which is adjacent to
gene D. One insertion creates a premature stop codon in gene C, three
codons upstream from the natural stop codon (Fig.
4). The natural stop codon overlaps with
the gene D start codon. The premature stop codon overlaps with the
ribosome binding site (RBS) of gene D. C protein termination and D
protein initiation may now be more efficiently coupled than in the wild
type. In addition, the insertion may create an RBS that can more easily
anneal to the 16S rRNA. The second insertion is found between the D
gene RBS and start codon. These considerations suggest that part of the
ForDr phenotype may involve increasing wild-type D protein,
as opposed to a truncated C protein, synthesis.
 |
DISCUSSION |
Foreign external scaffolding proteins are potent cross-species
inhibitors of viral morphogenesis. The Microviridae
scaffolding proteins have diverged only 26% on the amino acid level,
and this divergence is localized to two distinct regions:
helix 1 and loop 6/
helix 7 in the atomic structure. Chimeric proteins were designed to separate these two domains in order to determine their individual inhibitory effects. The results of this analysis suggest that both domains are responsible for some level of inhibition and
demonstrate the feasibility of using closely related proteins as
antiviral agents.
The efficiency of inhibition ascribed to each domain differs and
appears to be concentration dependent. Low levels of induction are
sufficient when the inhibited virus and
helix 1 of the chimeric protein are of the same origin. This suggests that
helix 1 may play
a critical role in the self-association of D proteins into dimers or
dimer recognition of other structural proteins. Within the atomic
structure of the procapsid, four D proteins associate with the viral
coat protein. The D proteins are arranged as asymmetric dimers of
dimers, D1D2 and D3D4, and are not related by quasi-equivalence (2, 3). Residues between
helices 2 and 6 mediate the
vast majority of the intradimer and interdimer contacts. This region of
the
X174 and
3 D proteins exhibits 96% conservation on the amino
acid level. This high level of conservation most likely allows
interspecies oligomerization, effectively diluting the amount of
indigenous protein capable of progressing through assembly as
homodimers. However,
helix 1 mediates some intradimer contacts, but
only in the D1D2 species. Without these contacts, dimers with a foreign
helix 1 may not be efficiently placed into the D1D2 position.
However, once placed into the D1D2 position, that helix makes no
contacts with other scaffolding or structural proteins.
Some coat-scaffolding interactions may not be apparent in the current
atomic structure. During crystallization, the
X174 procapsid matured
at the threefold axes of symmetry, producing a closed structure. The
native, or open, structure has pores at the threefold axes. Genetic
data (4, 7) suggest that an interaction may occur between D4
helix 1 and
helix 4 of the viral coat protein. Both helices are
found at the threefold axis of symmetry in the closed structure. In an
open structure, the coat protein helix could be shifted upward and
might contact
helix 1 of the D4 subunit, which is the most closely
associated with underlying coat protein. Both helices are amphipathic
and could interact via hydrophobic interfaces. If this interaction is
indeed present in the native structure, this may exclude dimers with a
foreign
helix 1 from the D3D4 position.
Finally, contacts made by
helix 1 may be important in forming an
assembly naive dimer, from which the D1D2 and D3D4 are formed. All
three models are consistent with the high-level induction conditions
needed for proteins with a foreign
helix 1 and the absence of large
particles. Further analyses will be required to distinguish between
these models. The isolation of the resistant mutants described here is
limited. The selection procedures would not have generated mutations
within the cloned foreign or chimeric genes. Considering the low level
of inhibition conferred by chimeric scaffolding proteins with foreign
helices 1, it should be possible to construct the chimeric gene
directly within the
X174 genome and select for mutants which can
propagate without concurrent expression of a cloned wild-type gene.
The mechanism of inhibition conferred by foreign COOH termini, on the
other hand, is more apparent. The
X174 chiDr
mutant alters viral protein A, a component of the genome
biosynthesis/packaging machinery, which binds the procapsid along the
twofold axis of symmetry. The location of the
chiDr mutation and the isolation of procapsids
from cells expressing the chimeric protein suggest that chimeric and
wild-type scaffolding proteins form procapsids that cannot interact
with the genome biosynthetic/packaging machinery. Because the
chiDr phenotype does not circumvent the need for the
wild-type protein, chimeric and wild-type proteins can achieve
conformations needed for chiDr A protein
recognition that chimeras alone cannot achieve. Nor does the mutation
confer resistance to the expression of the wild-type
3 D protein or
the
3/
X chimera, consistent with a model in which foreign
scaffolding proteins confer multiple blocks in morphogenesis.
In the COOH termini, only the regions comprising loop 6 and
helix 7 have diverged between the
X174 and
3 proteins.
helix 7 is
ordered only in the D4 subunit, in which it makes multiple contacts
with the underlying coat. While the D protein amino acids participating
in these contacts have diverged, albeit conservatively, the target
residues in the
X174 and
3 coat proteins are identical. These
observations suggest that the highly divergent loop 6 may be
responsible for recognizing the genome biosynthetic/packaging machinery
or forming part of its docking interface. With the identification of
the chiDr mutations, the chimeric D gene can be
placed directly into a chiDr background. The
chimeric virus can be propagated in cells expressing the wild-type D
protein. A direct and simple selection, the loss of
complementation-dependent growth, can be used to isolate mutants that
can utilize only the chimeric protein or a mutated form.
 |
ACKNOWLEDGMENT |
This study was supported by a grant from the National Science
Foundation to B.A.F.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Sciences and Microbiology, University of Arizona, Tucson, AZ
85721. Phone: (520) 626-6634. Fax: (520) 621-6366. E-mail: bfane{at}u.arizona.edu.
 |
REFERENCES |
| 1.
|
Burch, A. D.,
H. J. Ta, and B. A. Fane.
1999.
Cross-functional analysis of the Microviridae internal scaffolding protein.
J. Mol. Biol.
286:95-104[CrossRef][Medline].
|
| 2.
|
Dokland, T.,
R. McKenna,
L. L. Ilag,
B. R. Bowen,
N. L. Incardona,
B. A. Fane, and M. G. Rossmann.
1997.
Structure of a viral assembly intermediate with molecular scaffolding.
Nature
389:308-313[CrossRef][Medline].
|
| 3.
|
Dokland, T.,
R. A. Bernal,
A. D. Burch,
S. Pletnev,
B. A. Fane, and M. G. Rossmann.
1999.
The role of scaffolding proteins in the assembly of the small, single-stranded DNA virus X174.
J. Mol. Biol.
288:595-608[CrossRef][Medline].
|
| 4.
|
Ekechukwu, M. C., and B. A. Fane.
1995.
Characterization of the morphogenetic defects conferred by cold-sensitive prohead accessory and scaffolding proteins of X174.
J. Bacteriol.
177:829-830[Abstract/Free Full Text].
|
| 5.
|
Ekechukwu, M. C.,
D. J. Oberste, and B. A. Fane.
1995.
Host and X174 mutations which affect the morphogenesis or stabilization of the 50S complex, a single stranded DNA synthesizing intermediate.
Genetics
140:1167-1174[Abstract].
|
| 6.
|
Fane, B. A., and M. Hayashi.
1991.
Second-site suppressors of a cold-sensitive prohead accessory protein of bacteriophage X174.
Genetics
128:663-671[Abstract].
|
| 7.
|
Fane, B. A.,
S. Shien, and M. Hayashi.
1993.
Second-site suppressors of a cold sensitive external scaffolding protein of bacteriophage X174.
Genetics
134:1003-1011[Abstract].
|
| 8.
|
Hayashi, M.,
A. Aoyama,
D. L. Richardson, and M. N. Hayashi.
1988.
Biology of the bacteriophage X174, p. 1-71.
In
R. Calendar (ed.), The bacteriophages, vol. 2. Plenum Publishing Corporation, New York, N.Y.
|
| 9.
|
Jennings, B., and B. A. Fane.
1997.
Genetic analysis of the X174 DNA binding protein.
Virology
227:370-377[CrossRef][Medline].
|
| 10.
|
King, J., and S. Casjens.
1974.
Catalytic head assembling protein in virus morphogenesis.
Nature
251:112-119[CrossRef][Medline].
|
| 11.
|
Kodaira, K.,
K. Nakano,
S. Okada, and A. Taketo.
1992.
Nucleotide sequence of the genome of bacteriophage 3: interrelationship of the genome structure and the gene products with those of the phages X174, G4 and øK.
Biochem. Biophys. Acta
113:277-288.
|
| 12.
|
Liebowitz, J., and M. S. Horowitz.
1975.
Synthesis and assembly of adenovirus polypeptides. III. Reversible inhibition of hexon assembly in adenovirus type 5 temperature-sensitive mutants.
Virology
66:10-24[CrossRef][Medline].
|
| 13.
|
Marvik, O. J.,
T. Dokland,
R. H. Nokling,
E. Jacobsen,
T. Larsen, and B. J. Lindqvist.
1995.
The capsid size-determining protein sid forms an external scaffold on phage P4 procapsids.
J. Mol. Biol.
251:59-75[CrossRef][Medline].
|
| 14.
|
McKenna, R.,
L. L. Ilag, and M. G. Rossmann.
1994.
Analysis of the single-stranded DNA bacteriophage X174 at a resolution of 3.0 Å.
J. Mol. Biol.
237:517-543[CrossRef][Medline].
|
| 15.
|
McKenna, R.,
D. Xia,
P. Willingmann,
L. L. Ilag,
S. Krishnaswamy,
M. G. Rossmann,
N. H. Olson,
T. S. Baker, and N. L. Incardonna.
1992.
Atomic structure of single-stranded DNA bacteriophage X174 and its functional implications.
Nature
355:137-143[CrossRef][Medline].
|
| 16.
|
Prevelige, P. E.,
D. Thomas, and J. King.
1993.
Nucleation and growth phage in the polymerization of coat scaffolding subunits into icosadhedral procapsid shells.
J. Biophys.
64:824-835[Abstract/Free Full Text].
|
| 17.
|
Rixon, F. J.
1993.
Structure and assembly of herpes viruses.
Semin. Virol.
4:135-144.
|
| 18.
|
Roof, W. D.,
S. M. Horne,
K. D. Young, and R. Young.
1994.
SlyD, a host gene required for X174 lysis, is related to the FK506-binding protein family of peptidyl-prolyl cis-trans-isomerases.
J. Biol. Chem.
269:2902-2910[Abstract/Free Full Text].
|
| 19.
|
Rossmann, M. G.
1984.
Constraints on the assembly of spherical virus particles.
Virology
134:1-13[CrossRef][Medline].
|
| 20.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 21.
|
Sanger, F.,
A. R. Coulson,
C. T. Friedmann,
G. M. Air,
B. G. Barrell,
N. L. Brown,
J. C. Fiddes,
C. A. Hutchison III,
P. M. Slocombe, and M. Smith.
1978.
The nucleotide sequence of bacteriophage X174.
J. Mol. Biol.
125:225-246[CrossRef][Medline].
|
| 22.
|
Siden, E. J., and M. Hayashi.
1974.
Role of gene B product in bacteriophage X174 development.
J. Mol. Biol.
89:1-16[CrossRef][Medline].
|
| 23.
|
Spencer, J. V.,
W. W. Newcomb,
D. R. Thomsen,
F. L. Homa, and J. C. Brown.
1998.
Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid.
J. Virol.
72:3944-3951[Abstract/Free Full Text].
|
Journal of Virology, October 2000, p. 9347-9352, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cherwa, J. E. Jr., Uchiyama, A., Fane, B. A.
(2008). Scaffolding Proteins Altered in the Ability To Perform a Conformational Switch Confer Dominant Lethal Assembly Defects. J. Virol.
82: 5774-5780
[Abstract]
[Full Text]
-
Uchiyama, A., Chen, M., Fane, B. A.
(2007). Characterization and Function of Putative Substrate Specificity Domain in Microvirus External Scaffolding Proteins. J. Virol.
81: 8587-8592
[Abstract]
[Full Text]
-
Poon, A., Chao, L.
(2005). The Rate of Compensatory Mutation in the DNA Bacteriophage {phi}X174. Genetics
170: 989-999
[Abstract]
[Full Text]
-
Uchiyama, A., Fane, B. A.
(2005). Identification of an Interacting Coat-External Scaffolding Protein Domain Required for both the Initiation of {phi}X174 Procapsid Morphogenesis and the Completion of DNA Packaging. J. Virol.
79: 6751-6756
[Abstract]
[Full Text]
-
Hafenstein, S., Fane, B. A.
(2002). {phi}X174 Genome-Capsid Interactions Influence the Biophysical Properties of the Virion: Evidence for a Scaffolding-Like Function for the Genome during the Final Stages of Morphogenesis. J. Virol.
76: 5350-5356
[Abstract]
[Full Text]